Indoco Remedies Ltd has announced on Friday, the receipt of GCP & GLP Accreditation from the UK-MHRA
(Medicines and Healthcare Products Regulatory Agency) for its Clinical Research Organisation - AnaCipher,
located at Hyderabad for the virtual inspection carried out from May 4-7 and May 10-11, 2021.
The inspection covered all the phases of Bioequivalence studies and was conducted successfully.
“This is an exciting step in our journey of excellence and a validation of our adherence to delivering quality
services to our customers worldwide.”, stated Aditi Kare Panandikar, Managing Director, Indoco Remedies Limited.
AnaCipher CRO, based in Hyderabad, is a USFDA inspected clinical research facility and is spread over 30,000 sq. ft
area with 98 beds and staffed by experienced professionals providing clinical trial solutions and conducts
Bioequivalence and Bioavailability (BA/BE) studies at its facility.
|